Molecular Cyclotrons Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
- Paid Up Capital ₹ 3.50 Cr
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
- Satisfied Charges ₹ 10.26 Cr
- Revenue Growth 17.19%
- Profit Growth 79.34%
- Ebitda 25.13%
- Net Worth -2.38%
- Total Assets -6.37%
About Molecular Cyclotrons
Molecular Cyclotrons Private Limited (MCPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 29 June 2011 and has a history of 13 years and seven months. Its registered office is in Trichur, Kerala, India.
The Corporate was formerly known as Ceevees Medical Radioisotopes Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 3.50 Cr.
The company currently has active open charges totaling ₹1.00 Cr. The company has closed loans amounting to ₹10.26 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kizhakkebhagathu Joy, Methale Kunhi, Mathew Kattukkaran, and Two other members serve as directors at the Company.
Company Details
- Location
Trichur, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U52310KL2011PTC028744
- Company No.
028744
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jun 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Molecular Cyclotrons?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kizhakkebhagathu Joy  | Managing Director | 29-Jun-2011 | Current |
| Chirayath Varkey | Managing Director | 29-Jun-2011 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mibu Jose | Director | 01-Sep-2012 | Current |
| Methale Kunhi | Director | 01-Sep-2012 | Current |
| Mathew Kattukkaran | Director | 01-Sep-2012 | Current |
Financial Performance of Molecular Cyclotrons.
Molecular Cyclotrons Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.19% increase. The company also saw a substantial improvement in profitability, with a 79.34% increase in profit. The company's net worth dipped by a decrease of 2.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Molecular Cyclotrons?
In 2023, Molecular Cyclotrons had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medtech Remedies Private LimitedMethale Kunhi is a mutual person
Maxvalue Nidhi LimitedChirayath Varkey is a mutual person
Maxvalue Chits Private LimitedChirayath Varkey is a mutual person
Kannur International Airport LimitedMethale Kunhi is a mutual person
Verteil Technologies Private LimitedMethale Kunhi is a mutual person
Asset Homes Private LimitedMethale Kunhi is a mutual person
Charges (Loans)
₹1.00 Cr
₹10.26 Cr
Charges Breakdown by Lending Institutions
- The Catholic Syrian Bank Ltd : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Sep 2021 | The Catholic Syrian Bank Ltd | ₹1.00 Cr | Open |
| 28 Sep 2021 | The Catholic Syrian Bank Ltd | ₹4.40 M | Satisfied |
| 30 Sep 2014 | Others | ₹2.19 Cr | Satisfied |
| 01 Jul 2014 | Others | ₹7.63 Cr | Satisfied |
How Many Employees Work at Molecular Cyclotrons?
Unlock and access historical data on people associated with Molecular Cyclotrons, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Molecular Cyclotrons, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Molecular Cyclotrons's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.